• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞衰老、多细胞器功能障碍与动脉粥样硬化

Cell Senescence, Multiple Organelle Dysfunction and Atherosclerosis.

机构信息

CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, 1169-056 Lisboa, Portugal.

出版信息

Cells. 2020 Sep 23;9(10):2146. doi: 10.3390/cells9102146.

DOI:10.3390/cells9102146
PMID:32977446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7598292/
Abstract

Atherosclerosis is an age-related disorder associated with long-term exposure to cardiovascular risk factors. The asymptomatic progression of atherosclerotic plaques leads to major cardiovascular diseases (CVD), including acute myocardial infarctions or cerebral ischemic strokes in some cases. Senescence, a biological process associated with progressive structural and functional deterioration of cells, tissues and organs, is intricately linked to age-related diseases. Cell senescence involves coordinated modifications in cellular compartments and has been demonstrated to contribute to different stages of atheroma development. Senescence-based therapeutic strategies are currently being pursued to treat and prevent CVD in humans in the near-future. In addition, distinct experimental settings allowed researchers to unravel potential approaches to regulate anti-apoptotic pathways, facilitate excessive senescent cell clearance and eventually reverse atherogenesis to improve cardiovascular function. However, a deeper knowledge is required to fully understand cellular senescence, to clarify senescence and atherogenesis intertwining, allowing researchers to establish more effective treatments and to reduce the cardiovascular disorders' burden. Here, we present an objective review of the key senescence-related alterations of the major intracellular organelles and analyze the role of relevant cell types for senescence and atherogenesis. In this context, we provide an updated analysis of therapeutic approaches, including clinically relevant experiments using senolytic drugs to counteract atherosclerosis.

摘要

动脉粥样硬化是一种与长期暴露于心血管危险因素相关的与年龄相关的疾病。动脉粥样硬化斑块的无症状进展导致主要心血管疾病(CVD),在某些情况下包括急性心肌梗死或脑缺血性中风。衰老,与细胞、组织和器官的进行性结构和功能恶化相关的生物学过程,与与年龄相关的疾病密切相关。细胞衰老涉及细胞区室的协调修饰,并已被证明有助于动脉粥样硬化发展的不同阶段。目前正在研究基于衰老的治疗策略,以在不久的将来治疗和预防人类的 CVD。此外,不同的实验设置使研究人员能够揭示潜在的调节抗细胞凋亡途径、促进过度衰老细胞清除的方法,最终逆转动脉粥样硬化以改善心血管功能。然而,需要更深入的了解来充分理解细胞衰老,阐明衰老和动脉粥样硬化的交织,使研究人员能够建立更有效的治疗方法并减少心血管疾病的负担。在这里,我们对主要细胞内细胞器的关键衰老相关改变进行了客观的综述,并分析了相关细胞类型在衰老和动脉粥样硬化形成中的作用。在这种情况下,我们提供了治疗方法的最新分析,包括使用衰老细胞清除药物来对抗动脉粥样硬化的临床相关实验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d84/7598292/a38f2fc289ff/cells-09-02146-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d84/7598292/497cf9708f12/cells-09-02146-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d84/7598292/a38f2fc289ff/cells-09-02146-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d84/7598292/497cf9708f12/cells-09-02146-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d84/7598292/a38f2fc289ff/cells-09-02146-g002.jpg

相似文献

1
Cell Senescence, Multiple Organelle Dysfunction and Atherosclerosis.细胞衰老、多细胞器功能障碍与动脉粥样硬化
Cells. 2020 Sep 23;9(10):2146. doi: 10.3390/cells9102146.
2
Advances in relationship between cell senescence and atherosclerosis.细胞衰老与动脉粥样硬化关系的研究进展。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Feb 25;51(1):95-101. doi: 10.3724/zdxbyxb-2021-0270.
3
Cells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice.动脉粥样硬化中的细胞:从基础科学到临床实践聚焦于细胞衰老。
Int J Mol Sci. 2023 Dec 5;24(24):17129. doi: 10.3390/ijms242417129.
4
Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.衰老和衰老细胞清除在心血管疾病中的应用:前景与潜在风险。
Mech Ageing Dev. 2021 Sep;198:111540. doi: 10.1016/j.mad.2021.111540. Epub 2021 Jul 6.
5
Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence.衰老与动脉粥样硬化:细胞衰老的机制、功能后果和潜在治疗方法。
Circ Res. 2012 Jul 6;111(2):245-59. doi: 10.1161/CIRCRESAHA.111.261388.
6
Senescence mechanisms and targets in the heart.心脏衰老的机制和靶点。
Cardiovasc Res. 2022 Mar 25;118(5):1173-1187. doi: 10.1093/cvr/cvab161.
7
Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.糖尿病中的细胞衰老:脂肪组织和胰腺 β 细胞的独特衰老治疗策略。
Front Endocrinol (Lausanne). 2022 Mar 31;13:869414. doi: 10.3389/fendo.2022.869414. eCollection 2022.
8
Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.长期衰老细胞溶解疗法可缓解老年或动脉粥样硬化小鼠已有的血管舒缩功能障碍。
Aging Cell. 2016 Oct;15(5):973-7. doi: 10.1111/acel.12458. Epub 2016 Aug 5.
9
Therapeutic Potential of Senolytics in Cardiovascular Disease.衰老细胞清除疗法在心血管疾病中的治疗潜力。
Cardiovasc Drugs Ther. 2022 Feb;36(1):187-196. doi: 10.1007/s10557-020-07075-w. Epub 2020 Sep 26.
10
The emerging role of cell senescence in atherosclerosis.细胞衰老在动脉粥样硬化中的新兴作用。
Clin Chem Lab Med. 2020 Jul 21;59(1):27-38. doi: 10.1515/cclm-2020-0601.

引用本文的文献

1
Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons.氧化应激驱动的细胞衰老:机制串扰与治疗前景
Antioxidants (Basel). 2025 Aug 12;14(8):987. doi: 10.3390/antiox14080987.
2
Mechanisms of Leydig Cell Aging and Obesity-Related Hypogonadism in Men: A Review.男性睾丸间质细胞衰老及肥胖相关性腺功能减退的机制:综述
Med Sci Monit. 2025 Aug 3;31:e948180. doi: 10.12659/MSM.948180.
3
Nucleic acid drugs: recent progress and future perspectives.核酸药物:最新进展与未来展望。

本文引用的文献

1
Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells.雷帕霉素通过调控人心脏祖细胞中的 STAT3-PIM1 轴抑制细胞复制性衰老并改善细胞功能。
Exp Mol Med. 2020 Apr;52(4):615-628. doi: 10.1038/s12276-020-0374-4. Epub 2020 Apr 9.
2
Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence.线粒体到细胞核的逆行信号转导驱动衰老时细胞质染色质和炎症的形成。
Genes Dev. 2020 Mar 1;34(5-6):428-445. doi: 10.1101/gad.331272.119. Epub 2020 Jan 30.
3
Signal Transduct Target Ther. 2024 Nov 29;9(1):316. doi: 10.1038/s41392-024-02035-4.
4
Nrf2 Connects Cellular Autophagy and Vascular Senescence in Atherosclerosis: A Mini-Review.Nrf2在动脉粥样硬化中连接细胞自噬与血管衰老:一篇综述。
J Lipid Atheroscler. 2024 Sep;13(3):292-305. doi: 10.12997/jla.2024.13.3.292. Epub 2024 Apr 18.
5
What improvements do general exercise training and traditional Chinese exercises have on knee osteoarthritis? A narrative review based on biological mechanisms and clinical efficacy.一般运动训练和传统中式运动对膝骨关节炎有哪些改善作用?一项基于生物学机制和临床疗效的叙述性综述。
Front Med (Lausanne). 2024 May 22;11:1395375. doi: 10.3389/fmed.2024.1395375. eCollection 2024.
6
SGLT2i Alleviates Atherosclerosis by Inhibiting NHE1 Activation to Protect against Macrophage Senescence Induced by Angiotensin II.钠-葡萄糖协同转运蛋白2抑制剂通过抑制NHE1激活减轻动脉粥样硬化,以预防血管紧张素II诱导的巨噬细胞衰老。
Comb Chem High Throughput Screen. 2025;28(10):1754-1765. doi: 10.2174/0113862073310500240514045321.
7
Cellular senescence in cancer: molecular mechanisms and therapeutic targets.癌症中的细胞衰老:分子机制与治疗靶点
MedComm (2020). 2024 Apr 24;5(5):e542. doi: 10.1002/mco2.542. eCollection 2024 May.
8
Targeting Cellular Senescence in Aging and Age-Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies.靶向衰老和与年龄相关疾病中的细胞衰老:挑战、考虑因素以及衰老溶解和衰老模拟疗法的新兴作用。
Aging Dis. 2024 Feb 27;15(6):2554-2594. doi: 10.14336/AD.2024.0206.
9
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence.PURPL和NEAT1长链非编码RNA在血管平滑肌细胞复制性衰老中受到调控。
Biomedicines. 2023 Dec 6;11(12):3228. doi: 10.3390/biomedicines11123228.
10
The Protective Effects of Eicosapentaenoic Acid for Stress-induced Accelerated Senescence in Vascular Endothelial Cells.二十碳五烯酸对血管内皮细胞应激诱导加速衰老的保护作用。
Int J Med Sci. 2023 Sep 11;20(11):1479-1491. doi: 10.7150/ijms.85224. eCollection 2023.
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis.
衰老诱导的炎症:动脉粥样硬化中的重要参与者和关键治疗靶点。
Eur Heart J. 2020 Aug 14;41(31):2983-2996. doi: 10.1093/eurheartj/ehz919.
4
Cardiac glycosides are broad-spectrum senolytics.强心苷是一种广谱的衰老细胞清除剂。
Nat Metab. 2019 Nov;1(11):1074-1088. doi: 10.1038/s42255-019-0122-z. Epub 2019 Oct 21.
5
ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis.内质网应激激活 NLRP3 炎性小体:动脉粥样硬化的新机制。
Oxid Med Cell Longev. 2019 Oct 7;2019:3462530. doi: 10.1155/2019/3462530. eCollection 2019.
6
Identification and characterization of Cardiac Glycosides as senolytic compounds.鉴定和表征心脏糖苷类化合物作为衰老细胞选择性溶解剂。
Nat Commun. 2019 Oct 21;10(1):4731. doi: 10.1038/s41467-019-12888-x.
7
Inhibition of Senescence-Associated Genes Rb1 and Meis2 in Adult Cardiomyocytes Results in Cell Cycle Reentry and Cardiac Repair Post-Myocardial Infarction.抑制衰老相关基因 Rb1 和 Meis2 可使成年心肌细胞重新进入细胞周期,并在心肌梗死后修复心脏。
J Am Heart Assoc. 2019 Aug 6;8(15):e012089. doi: 10.1161/JAHA.119.012089. Epub 2019 Jul 18.
8
Forkhead box O3 protects the heart against paraquat-induced aging-associated phenotypes by upregulating the expression of antioxidant enzymes.叉头框蛋白 O3 通过上调抗氧化酶的表达来保护心脏免受百草枯诱导的衰老相关表型。
Aging Cell. 2019 Oct;18(5):e12990. doi: 10.1111/acel.12990. Epub 2019 Jul 1.
9
Vascular smooth muscle cells in atherosclerosis.动脉粥样硬化中的血管平滑肌细胞。
Nat Rev Cardiol. 2019 Dec;16(12):727-744. doi: 10.1038/s41569-019-0227-9. Epub 2019 Jun 26.
10
Mitochondrial dysfunction and cell senescence: deciphering a complex relationship.线粒体功能障碍与细胞衰老:解析复杂关系。
FEBS Lett. 2019 Jul;593(13):1566-1579. doi: 10.1002/1873-3468.13498. Epub 2019 Jun 27.